Simon J. Cook. "Second MEK Inhibitor Shows Promise in Neurofibromatosis Type 1 With Symptomatic Plexiform Neurofibromas Signaling Hope for Other RASopathies." Journal of Clinical Oncology, 2025. doi:10.1200/jco-24-02375